Kennett Square, PA, United States of America

Andrew Paul Combs

This inventor holds 129 USPTO granted patents and 40 published patent applications, plus 5 CIPO patents and 30 EPO patents, primarily in PI3K Inhibitors (CPC class C07D471-04). Top assignees: Incyte Corporation, Incyte Holdings Corporation, Prelude Therapeutics Incorporated. Active years: 2005-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew Paul Combs. Retrieved from https://idiyas.com/inventor/andrew-paul-combs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 129 

% Patents Active = 90.7

 

 

Average Co-Inventor Count = 3.9

ph-index = 26

Forward Citations = 2,267(Granted Patents)

Forward Citations (Not Self Cited) = 1,228(Dec 10, 2025)


Inventors with similar research interests:

🔬 See more inventors

Location History:

  • Kenneth Square, PA (US) (2021)
  • Wilmington, DE (US) (2017 - 2023)
  • Kennett Square, PA (US) (2005 - 2024)

Company Filing History:


Years Active: 2005-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
PI3K Inhibitors
CDK Inhibitors
BET Protein Inhibitors
Aminopyrazine Derivatives
Heterocyclic Compounds
Tertiary Alcohols
Pyrazolopyrimidine Derivatives
Crystalline Forms
Bicyclic Derivatives
Tricyclic Heterocycles
Indoleamine Inhibitors
Heterocyclylamines
129 patents (USPTO):Explore Patents

Title: The Innovator Behind 115 Patents: Andrew Paul Combs

Introduction: Andrew Paul Combs is a prolific inventor based in Kennett Square, PA (US) with an impressive portfolio of 115 patents to his name. Combs is known for his groundbreaking work in developing compounds that have the potential to revolutionize the treatment of various diseases.

Latest Patents: Among his latest patents, Combs has secured groundbreaking innovations such as "Pyridine and pyridimine compounds as PI3K-gamma inhibitors" and "CDK inhibitors and their use as pharmaceuticals." These patents highlight Combs' expertise in modulating the activity of phosphoinositide 3-kinases-gamma (PI3Kγ) and developing pharmaceutical compositions for the treatment of diseases like autoimmune diseases, cancer, cardiovascular diseases, and neurodegenerative diseases.

Career Highlights: Combs has made significant contributions to the field of pharmaceuticals through his work at companies like Incyte Corporation and Incyte Holdings Corporation. His innovative approach to drug development has led to the creation of novel compounds that have the potential to improve the lives of patients worldwide.

Collaborations: Throughout his career, Combs has collaborated with esteemed colleagues such as Richard B Sparks and Eddy W Yue. These partnerships have been instrumental in driving forward innovative research and development initiatives in the pharmaceutical industry.

Conclusion: Andrew Paul Combs stands as a prominent figure in the world of inventors, with a remarkable track record of 115 patents to his credit. His innovative work in developing compounds for the treatment of various diseases showcases his dedication to advancing healthcare through cutting-edge research and development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…